Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New target-seeking molecule offers hope of better cancer treatment

21.04.2006


A new target-seeking affibody molecule can be used to visualize cancer tumors and to treat them. This has been shown in a dissertation by Ann-Charlott Steffen to be publicly defended at Uppsala University on April 22.


The gamma camera image shows the distribution of radioactivity in a mouse given target-seeking affibody molecules marked with radioactivity. The uptake can be seen in the thyroid gland, the kidneys, and the tumor.



Every third Swede is estimated to receive a cancer diagnosis sometime in their lives, and nearly one Swede in four dies as a result of the disease. The need for improved detection and treatment of the disease is great.

Existing treatments include surgery, chemotherapy, and radiation. Surgery is most effective for large, well-defined tumors, but if the disease has spread, chemotherapy and/or radiation are needed. These forms of treatment affect all dividing cells, leading to toxic effects on healthy tissue. This toxicity limits the size of the dose that can be given, thereby also limiting the probability that the disease will be cured. By seeking out tumor cells and selectively delivering cytostatics or radiation to the cancer cells, the dose affecting healthy tissue can be reduced and the dose to the tumor can be increased. This improves the chances of curing the disease.


Ann-Charlott Steffen and her associates have developed an affibody molecule that binds to the protein HER-2, which primarily occurs in cancer cells from patients with aggressive forms of breast cancer. The scientists have attached radioactivity to the affibody molecules, so that they can visualize tumors and metastases and also treat tumors with the local dose of radiation provided by this radioactivity.

Ann-Charlott Steffen shows that the HER-2-binding affibody molecules attach to cancer cells with the HER-2 target on their surface, both in cell cultures and in mouse tumors. The research team has also found that the radioactivity in mouse tumors can be used to make these tumors visible in a gamma camera (see picture). Moreover, the results show that the radioactivity delivered by the affibody molecules can be used to kill tumor cells in cell cultures.

Affibody molecules are tiny, which enables them to enter tumors and be rapidly distributed in the body, unlike antibodies, which are normally used in target-seeking therapy and visualization. What’s more, affibody molecules are relatively easy to develop for virtually any target and can therefore in all probability be used for visualizing and treating many different forms of cancer.

“I hope these findings will lead to new possibilities of visualizing and treating distributed tumor diseases so that more cancer patients will be able to survive,” says Ann-Charlott Steffen.

Linda Nohrstedt | alfa
Further information:
http://info.uu.se/press.nsf/pm/new.targetseeking.idAE4.html

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>